Consortium board

Jutta Reinhard-Rupp


Dr Jutta Reinhard-Rupp is the Head of the Global Health Institute at Merck, based in Switzerland. Her focus is the discovery and development of innovative healthcare solutions including drugs, diagnostics and devices for most vulnerable populations such as children and their mothers in developing countries. The disease focus of the institute is on Schistosomiasis, Malaria and emerging antimicrobial resistance. Jutta received her PhD at the Max-Planck Institute in Tübingen and after her postdoctoral training, she joined biopharmaceutical industry in various assignments. She also serves as scientific advisor at various boards, including CouNTDown in the UK and EDCTP.

Peter Bonate


Peter Bonate has more than 20 years industry experience and is currently the Executive Director of the Pharmacokinetics, Modeling, & Simulation Group at Astellas.  He has a PhD in Medical Neurobiology, an MS in Statistics, and an MS in Pharmacology/Toxicology.  He is a fellow of the American Association of Pharmaceutical Scientists (AAPS) and American College of Clinical Pharmacology.  An expert in clinical pharmacology and the mathematical modeling of clinical and pharmacokinetic data, in 2015, he was the recipient of the Clinical Pharmacology and Translation Research Achievement Award from AAPS.

Jennifer Keiser

Swiss TPH

Jennifer Keiser is an Associate Professor at the Department of Medical Parasitology and Infection Biology at the Swiss Tropical and Public Health Institute (Swiss TPH). She is heading the Helminth Drug Development Unit, which maintains many helminth rodent models including Schistosoma mansoni. Research objectives of her team include in vitro and in vivo evaluation of compounds, preclinical studies such as pharmacokinetics and metabolism, mechanism of action studies and clinical trials in endemic countries.

Fofana Al Hassane

University Felix Houphouet-Boigny

Dr Hassane is the Director of Human Resources of the University Felix Houp houet-Boigny since November 2016. Before that he was the Director in charge of Personnel Teachers and Researchers at the Ministry of Higher Education and Scientific Research for more than 5 years. Holder of a PhD in Industrial Process Engineering from the Compiègne University of Technology in France, he is a physics teacher at UFHB, a specialist in thermal and energetics. He has been a member of several European and African projects.

Lynsey Blair

Schistosomiasis Control Initiative

Dr Lynsey Blair is the Head of Programmes at the Schistosomiasis Control Initiative (SCI), School of Public Health at Imperial College London. She holds a PhD and has been involved in schistosomiasis control for 20 years both in research and the provision of technical expertise. She currently leads a team of Programme Advisors working in multi-country settings across sub-Saharan Africa supporting endemic country Governments in the implementation of large-scale preventive chemotherapy for schistosomiasis and intestinal worm infections.

Veronica Manduku


Dr.Veronica Manduku is the Director Centre for Clinical research in KEMRI Kenya since November 2017. She heads a team of scientific experts in infectious and Non-communicable disease research including specialist clinicians, trialists, nurses and laboratory personnel who work at  various units across the country. She is a Medical imaging specialist having graduated in 2004, MMED Diagnostic imaging. She has worked in malaria vaccine, Pneumonia studies and was lead imaging expert in the Kenya National TB survey. She is also a board member of the African society of radiology and sits at the Kenya radiation protection Board. She chairs the Kenya society of ultrasound in medicine and Biology, a membership professional body.

Bert Leufkens


Dr Leufkens obtained his PharmD and PhD degree from Utrecht University. In 1997 he was appointed as full professor of Pharmacoepidemiology at Utrecht University. From 2003-2005 he was the Scientific Director of the Utrecht Institute for Pharmaceutical Sciences, and during 2006-2007 head of the Department of Pharmaceutical Sciences of the Faculty of Science in Utrecht. Dr Leufkens is a past-member EMA Pharmacovigilance Working Party 2005-2009 and CHMP 2009-2015, chair of Dutch Medicines Evaluation Board 2007-2017, and since 2008 Scientific Director of the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation. In January 2018, he joined Lygature as scientific leader.

Juliana Johansson Soares Medeiros


Juliana Johansson Soares Medeiros is the Head of Technology Development in Farmanguinhos, a unit of Fiocruz Foundation and the official pharmaceutical laboratory of Brazilian Ministry of Health. She is pharmacist and works since 2002 with Pharmaceutical Development projects, holds a Master in the same area and her doctoral degree in ongoing. Her work team is composed of specialists in Pharmaceutical Technology, Analytical Development and Management in projects of pharmaceutical development for Brazilian public health system.

Janina Steinert

Technical University of Munich

Janina Steinert is an Assistant Professor at the TUM School of Governance, Technical University of Munich and a Research Associate at the Department of Social Policy and Intervention, University of Oxford – from where she has also obtained her PhD. Janina’s research interest lies primarily in the fields of global health and development economics. He research topics include poverty alleviation, HIV/AIDS, inter-personal violence, female empowerment, and research ethics. She has conducted two randomised controlled trials in South Africa and India and has used behavioural games in more recent work.